Medical foods and nutritional supplements for the dietary management of acute viral infections, Long COVID and GLP-1 related muscle loss & other side effects.
Additionally, for clarity, virtually all shares (95%+) issued in this transaction will be restricted with lock-ups. The float will remain virtually untouched. This is about the long term opportunity to gain a significant stake in the IP needed for the future of healthcare
$MEDS
DataMEDS AI Enters Into Amended and Restated LOI to License and Acquire IP that Enables Goal-Driven Prescription Drug Telehealth, Medical Drones and Healthcare Blockchain Technologies $MEDS #MEDS
Read the full press release for more: https://t.co/ISc2yNbFDG
DataMEDS AI Regains Compliance With NASDAQ Listing Standards $MEDS #MEDS
Read our full press release for complete details and disclosures: https://t.co/bqNzekX8P6
The latest data reveals hospital AI coding tools added nearly $1B in costs without improving patient care.
Appearing on @NewsNation, $MEDS Interim Co-CEO Gerald Commissiong explained how the current system rewards coding and billing optimization over actual patient outcomes.
DataMEDS AI Files DBAs DataMEDS SI And Corexa Health SI And Reminds Shareholders Of Record As Of August 7, 2026 Of Dream Bowl Meme Coin I Payment $MEDS
Read our full press release for complete details and disclosures: https://t.co/c8RlnAQAde
#CorexaPharmacy recorded a preliminary $1 million in unaudited revenue for September 2026 - a 66 percent increase from July. @corexahealth $MEDS
Real the full press release to learn more: https://t.co/9nsKX7uNxS
DataMeds AI and @TolloHealth Announce Launch of 'Health Lives Here' Mobile Application. $MEDS #MEDS
Read the full press release here to learn more: https://t.co/auKw8LbubO
DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic Cancers $MEDS
Read our full press release for complete details and disclosures: https://t.co/usCIMMrBDK
DataMEDS SI Provides Business Update on CLIA Lab Helomics and Its Super Intelligence Predictive Oncology Division. $MEDS
Company has Implemented Cost Control Measures and Refocused Remaining Workforce Efforts Towards ChemoFx® Commercialization.
https://t.co/TNiLoSnILh
DataMeds SI is bringing advanced care management to patients taking GLP-1 receptor agonist medications. Through our new exclusive agreement with REBOOT Health AI, we are integrating their proprietary platform into our Health Lives Here app. $MEDS
https://t.co/8Pz3IX2Chv
DataMEDS AI interim Co-CEO Gerald Commissiong spoke with @WSJ on the massive challenge of pricing accurately in today’s volatile market. $MEDS #MEDS
https://t.co/b6TNdGpvRc
DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Sharessked $MEDS #MEDS
Read our full press release for complete details and disclosures: https://t.co/T9p63gMcoY
DataMEDS AI’s digital evolution is complete! $MEDS #MEDS
Explore our newly redesigned corporate website at https://t.co/In3xp5PMvA
Read our full press release for more: https://t.co/3GjmaicPPd
DataMEDS AI Acquires Helomics AI Cancer Diagnostics Lab and Precision Oncology CRO Businesses from @AxeCompute. $MEDS #MEDS
Read our full press release for complete details and disclosures: https://t.co/xlrPKGUO29
Following our acquisition of @AxeCompute’s Helmomics platform, we're proud to see this foundational work scaling the future of precision medicine. $MEDS
Watch Axe Compute CEO Christopher Miglino on @FoxBusiness discussing AI in cancer research: https://t.co/tJFPHJ1hQi
True health tech innovation starts with solving real problems, not chasing trends. $MEDS
Read our Interim Co-CEO Gerald Commissiong’s latest feature in @CeoValiant: https://t.co/iYENZGMJ4q (https://t.co/us1j1IiDtJ)
Excited to announce that DataMeds AI will be presenting at the 2026 National Telehealth and Virtual Care Summit next week, sharing our vision for patient data ownership, reducing provider friction, and expanding care access. $MEDS #MEDS
Read more: https://t.co/QXlJzuCe0K
Co-CEO Gerald Commissiong spoke with @Benzinga to discuss how DataMEDS AI is tracking GLP-1 outcomes and driving long-entrenched growth across our ecosystem. $MEDS #MEDS
Read the full interview here: https://t.co/Bhl4QnGXuf
$MEDS Together with @TolloHealth and @nflalumnihealth , the #HealthLivesHere campaign gets underway. #DataMedsAI
Learn more about our partnership and how underserved rural communities are now empowered to take control of their health data: https://t.co/V6pW205F5B